Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
Hendrianus The, Interventional & Structural Cardiology Fellow at Heart and Brain Hospital, Chung-Ang University Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I would like to share our recently published meta-analysis evaluating intravenous cangrelor in hemodynamically unstable patients undergoing PCI.
We found that IV cangrelor was associated with reduced mortality, with the most pronounced benefit observed in patients with cardiogenic shock, along with improved coronary flow.
These findings support its role as a valuable alternative when oral P2Y12 inhibitor administration is not feasible, pending confirmation in large-scale randomized trials.”
Title: Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Authors: Hendrianus Hendrianus, Young-Hoon Jeong, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Diana A. Gorog, Jacek Kubica, Udaya S. Tantry, Paul A. Gurbel, Sang-Wook Kim
Read the Full Article on Critical Care
Stay updated with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear